MedinCell Publishes Its Financial Results for the First Semester Of 2022-2023 (April
Regulatory News: MedinCell (Paris:MEDCL): Revenue: €7.7 million (+89% compared to the first half of the previous year) Operating expenses: €19.4 million (+27% compared to the first half of
Source: finanznachrichten.de